Pelvalon
Pelvalon developed the Eclipse System, the first vaginal insert for non-surgical bowel control in women with fecal incontinence. Acquired by Laborie Medical Technologies in 2021 and distributed via U.S. physician offices under CMS reimbursement code A4563.
- Company typePrivate
- Founded2015
- HeadquartersSunnyvale, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pelvalon does
Pelvalon is a U.S.-based medical device company that developed and commercialized the Eclipse System, the first vaginal insert specifically designed to provide bowel control for women with fecal incontinence. The system consists of a vaginal insert with an inflatable balloon that compresses the rectum when inflated to prevent accidental passage of stool, paired with a patient-controlled pump, multi-size fitting sizers, and a range of pressure regulators (low/medium/high) and accessory components. The Eclipse Insert is a single-patient-use device intended for longer-term use (up to one year), and the Trial Insert supports physician-led fitting and evaluation.
Pelvalon firmographics
Firmographics- Name
- Pelvalon
- Legal name
- Pelvalon
- Website
- https://eclipsesystem.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Pelvalon developed the Eclipse System, the first vaginal insert for non-surgical bowel control in women with fecal incontinence. Acquired by Laborie Medical Technologies in 2021 and distributed via U.S. physician offices under CMS reimbursement code A4563.
- Ownership category
- akta.pro rank
Where Pelvalon is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Markets served
Pelvalon business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Eclipse Insert Device Sales: Revenue generated from the sale of Eclipse vaginal inserts (single-patient-use devices intended for longer-term use up to one year), Trial inserts (for fitting and evaluation), and accessory components including pumps, valves, regulators, and extension tubes. The device is reimbursed by CMS (A4563 – Vaginal inser rectal control sys) indicating insurance coverage for patients.
- Clinical Fitting Products: Revenue from reusable Sizers (clinical sizing tools) and single-patient-use Trial Inserts used during the physician office fitting and evaluation process.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Pelvalon product offering
Product offeringCore offering
Pelvalon developed the Eclipse System, a vaginal bowel-control medical device for women with fecal incontinence. The system uses an inflatable vaginal insert that, when activated, compresses the rectum to prevent accidental passage of stool, with a patient-controlled pump for inflation and deflation. The device is fitted in a physician's office and is reimbursed by CMS under HCPCS code A4563. The product line includes single-patient-use Trial Inserts (up to 2 weeks), Eclipse Inserts (up to 1 year), sizing tools, pumps, and supporting accessories.
Product overview
Pelvalon is a medical device company that developed the Eclipse System portfolio — the first vaginal insert designed to provide bowel control for women with fecal incontinence. The product line consists of the core Eclipse System, which includes Trial Inserts for fitting/evaluation (white, short-term use up to 2 weeks) and Eclipse Inserts for long-term use (indigo, up to 1 year), along with supporting components: the Pump for balloon inflation/deflation, Sizers for clinical fitting, and accessories (Valves, Regulators, Extension Tubes, Storage Cart). The company was acquired by Laborie Medical Technologies Corp. in October 2021, and the Eclipse System is now distributed under the Laborie brand.
Differentiator
Problem solved
Functional benefit
Brands
- Eclipse System: Vaginal insert designed to provide bowel control for women with fecal incontinence. The first vaginal insert of its kind, now part of Laborie's gastroenterology product portfolio.
Products and services
- Eclipse System A vaginal bowel-control medical device system designed to treat fecal incontinence (accidental bowel leakage) in women. The Eclipse System uses an inflatable vaginal insert that, when activated, expands to compress the rectum and prevent accidental stool passage. It offers an in-office, non-surgical treatment option with immediate results and no pharmaceutical side-effects. The system is fitted and provided directly in a physician's office setting and is CMS-reimbursed under HCPCS code A4563.
- Eclipse Trial Insert A single-patient-use vaginal insert used during the physician office fitting and evaluation process, intended for short-term use (approximately 1 week, but no more than 2 weeks). Available in multiple sizes (48mm, 51mm, 57mm Small and Regular; 64mm, 70mm, 76mm Elliptical Regular) and identifiable by white color.
- Eclipse Insert A single-patient-use vaginal insert intended for longer-term use (up to one year), identifiable by its indigo color. Available in multiple sizes matching the Trial Insert range.
- Eclipse Pump A patient-controlled pump used for inflating and deflating the Eclipse Insert Balloons, packaged with a medium Regulator and Patient Instructions For Use Booklet.
- Eclipse Sizers Reusable sizing tools representing the insert base, intended to aid clinicians in selecting appropriate Trial Insert sizes. Available in 48mm, 51mm, 57mm, 64mm, 70mm Round, and 76mm Elliptical. For clinical setting use only.
- Eclipse Accessories (Valves, Regulators, Extension Tubes, Storage Cart) Supporting components of the Eclipse System including replacement Valves (5 pack), Regulators in Low/Medium/High pressure options (5 pack), Extension Tubes for customizing tube length (5 pack), and a 4-drawer Storage Cart.
Quantifiable outcome
- 86.4% success rate at three months in pivotal study for women with minimum of four fecal episodes over two weeks
- +3 more outcomes
Companies that use Pelvalon
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Pelvalon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pelvalon partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Laborie Medical Technologies Corp.coreLaborie Medical Technologies Corp. acquired Pelvalon in October 2021. This acquisition brought the Eclipse System under Laborie's portfolio of urology and urogynecology medical devices. Laborie is headquartered in Portsmouth, NH and operates across urology, urogynecology, gastroenterology, and maternal & child health markets. The acquisition enables Laborie to offer the Eclipse System as part of its comprehensive pelvic floor disorder treatment portfolio.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Pelvalon competitors and assessment
Company assessmentBroad incumbents
- Hollister Incorporated: Hollister offers an ostomy and continence care portfolio (including bowel management products) sold through similar clinical channels, competing for the same specialist and patient relationships as Eclipse.
- Medtronic: Medtronic markets InterStim sacral neuromodulation systems, the leading non-surgical-but-surgical-implant alternative for fecal incontinence, directly competing with Eclipse for the same patient pool via a different mechanism.
- Coloplast: Coloplast operates a major continence care and ostomy franchise supplying catheters, pessaries, and bowel management products that share patient and channel overlap with Eclipse's bowel-control market.
- B. Braun Medical:
- Convatec: Convatec is a global continence and ostomy supplier with established reimbursement and distribution in bowel management, addressing the same underlying patient population as Pelvalon's Eclipse System.
Direct peers
- Axonics: Axonics develops sacral neuromodulation implants (Bulkamid, r-SNM) targeting urinary and fecal incontinence, overlapping directly with Eclipse in the same FI treatment pathway and physician audience.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Pelvalon social profiles
Digital presencePelvalon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pelvalon leadership team
Management profileNumber of profiles
Profiles2 records
Pelvalon funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pelvalon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pelvalon
What does Pelvalon do?
Pelvalon developed the Eclipse System, a vaginal bowel-control medical device for women with fecal incontinence. The system uses an inflatable vaginal insert that, when activated, compresses the rectum to prevent accidental passage of stool, with a patient-controlled pump for inflation and deflation. The device is fitted in a physician's office and is reimbursed by CMS under HCPCS code A4563. The product line includes single-patient-use Trial Inserts (up to 2 weeks), Eclipse Inserts (up to 1 year), sizing tools, pumps, and supporting accessories.
Is Pelvalon a public or private company?
Pelvalon is a private company. It is classified as corporate owned and is currently acquired.
When was Pelvalon founded?
Pelvalon was founded in 2015. It employs 11 to 50 people.
Where is Pelvalon based?
Pelvalon is headquartered in Sunnyvale, United States, in the North America region.
How does Pelvalon make money?
Two revenue lines are on record. Eclipse Insert Device Sales are the primary driver. The others are clinical Fitting Products.
Who are Pelvalon's main competitors?
Broad incumbents on record are Hollister Incorporated, Medtronic, Coloplast, B. Braun Medical and Convatec. Axonics is listed as a direct peer.
Does Pelvalon have an API?
No public API is recorded for Pelvalon.